Loading...
TG Therapeutics, Inc.
TGTX•NASDAQ
Healthcare
Biotechnology
$36.90
$0.37(1.01%)
TG Therapeutics, Inc. (TGTX) Financial Performance & Income Statement Overview
Review TG Therapeutics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
40.80%
↑ 40.80%
Operating Income Growth
103.21%
↑ 103.21%
Net Income Growth
84.52%
↑ 84.52%
Operating Cash Flow Growth
-28.98%
↓ 28.98%
Operating Margin
15.48%
↑ 15.48%
Gross Margin
87.43%
↑ 87.43%
Net Profit Margin
10.13%
↑ 10.13%
ROE
18.88%
↑ 18.88%
ROIC
12.05%
↑ 12.05%
TG Therapeutics, Inc. (TGTX) Income Statement & Financial Overview
Review TG Therapeutics, Inc.'s (TGTX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $108.19M | $83.88M | $73.47M | $63.47M |
| Cost of Revenue | $15.40M | $9.34M | $8.38M | $5.52M |
| Gross Profit | $92.79M | $74.54M | $65.09M | $57.95M |
| Gross Profit Ratio | $0.86 | $0.89 | $0.89 | $0.91 |
| R&D Expenses | $23.87M | $20.14M | $17.56M | $32.72M |
| SG&A Expenses | $38.96M | $41.97M | $38.72M | $34.50M |
| Operating Expenses | $62.84M | $62.10M | $56.27M | $67.22M |
| Total Costs & Expenses | $78.24M | $71.44M | $64.65M | $72.74M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $7.06M | $10.83M | $3.98M | $2.29M |
| Depreciation & Amortization | $62000.00 | $64000.00 | $72000.00 | $82000.00 |
| EBITDA | $32.07M | $15.10M | $10.60M | -$8.31M |
| EBITDA Ratio | $0.30 | $0.18 | $0.14 | -$0.13 |
| Operating Income | $29.95M | $12.43M | $8.82M | -$9.27M |
| Operating Income Ratio | $0.28 | $0.15 | $0.12 | -$0.15 |
| Other Income/Expenses (Net) | -$4.50M | -$8.17M | -$2.27M | -$1.41M |
| Income Before Tax | $25.45M | $4.27M | $6.55M | -$10.68M |
| Income Before Tax Ratio | $0.24 | $0.05 | $0.09 | -$0.17 |
| Income Tax Expense | $2.12M | $388000.00 | -$328000.00 | $29000.00 |
| Net Income | $23.33M | $3.88M | $6.88M | -$10.71M |
| Net Income Ratio | $0.22 | $0.05 | $0.09 | -$0.17 |
| EPS | $0.15 | $0.03 | $0.05 | -$0.07 |
| Diluted EPS | $0.15 | $0.02 | $0.04 | -$0.07 |
| Weighted Avg Shares Outstanding | $155.79M | $145.10M | $144.73M | $146.21M |
| Weighted Avg Shares Outstanding (Diluted) | $160.24M | $160.71M | $159.42M | $146.21M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan